Search

everythinglearnresearchcommunity

for

Search:↓

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A method was created to measure oxymatrine in human blood.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

The MEST method increases cell yield and volume for regenerative medicine but needs more testing.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Provenge extends prostate cancer survival by about 4 months.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Statins do not impact BPH and LUTS progression when combined with finasteride.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Agmatine may help reduce seizures linked to hormone changes in female rats.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.